1. Bevan, S., Hothi, S., Hughes, G. A., James, I. F., Rang, H. P., Shah, K., Walpole, C. S. J., and Yeats, J. C., Development of a competitive antagonist for the sensory neuron excitant, capsaicin.Br. J. Pharmacol., 102, 77 (1991).
2. Brand, L., Berman, E., Schwen, R., Loomans, M., Janusz, J., Bohne, R., Maddin, C., Gardner, J., Lahann, H., Farmer, R., Jones, L., Chiabrando, C. and Fanelli, R., NE-19550: A novel, orally active anti-inflammatory analgesic.Drugs Exp. Res., 8 259–265 (1987).
3. Holzer, P., Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides.Neuroscience, 24, 739–768 (1988).
4. Jancso, N., Desensitization with capsaicin and related acylamides as a tool for studying the function of pain receptors. In Lin, K., Armstrong, D., and Pardo, E. G. (Eds.),Pharmacology of Pain, Pergamon Press, Oxford, 1968, pp. 35–55.
5. Lee, B., Kim, J. H., Park, N. S. and Kong, J. Y., KR-25018: a novel orally active analgesic with nonnarcotic properties.Arch. Pharm. Res., 17, 304–308 (1994).